Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion description "[TRPM2 seems to be a candidate for gene therapy in glioblastoma cells, since the insertion of TRPM2 into A172 cells can facilitate cell death through Ca2+ increase after H2O2 treatment without increasing malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion evidence source_evidence_literature NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion SIO_000772 18225560 NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion wasDerivedFrom befree-20150227 NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_assertion wasGeneratedBy ECO_0000203 NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.
- befree-20150227 importedOn "2015-02-27" NP315632.RAOjNx_4sOOmYMdqNSlyFhGfX3aDcg0ARMR2nVR98Wj6A130_provenance.